This is mainly a concentration-and-expectations risk, not a science-project risk. The products are real and margins are strong, but the stock still needs proof that
Scorpio broadens beyond an initial lead ramp,
Leo becomes economic not just promotional, and Astera can keep premium content without being squeezed by
hyperscalers or larger platform vendors.